How Does Pathological Data Guide Treatment Decisions?
Treatment decisions in cancer care are heavily influenced by pathological data. For example, the presence of hormone receptors in breast cancer tissues can determine the use of hormone therapy. Similarly, the identification of specific genetic mutations, such as EGFR in lung cancer, can guide the use of targeted therapies. Pathological data ensures that treatments are specific to the cancer type and its biological characteristics, improving efficacy and reducing side effects.
